These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 21941413)

  • 1. Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.
    Gisbert JP; Chaparro M; Gomollón F
    World J Gastroenterol; 2011 Aug; 17(30):3467-78. PubMed ID: 21941413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
    Sedano Muñoz R; Quera Pino R; Ibáñez Lazo P; Figueroa Corona C; Flores Pérez L
    Gastroenterol Hepatol; 2019 May; 42(5):339-347. PubMed ID: 30954317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].
    Gisbert JP; Gomollón F; Cara C; Luna M; González-Lama Y; Pajares JM; Maté J; Guijarro LG
    Med Clin (Barc); 2005 Sep; 125(8):281-5. PubMed ID: 16159550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
    Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
    Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease.
    Bermejo F; Aguas M; Chaparro M; Domènech E; Echarri A; García-Planella E; Guerra I; Gisbert JP; López-Sanromán A;
    Gastroenterol Hepatol; 2018 Mar; 41(3):205-221. PubMed ID: 29357999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Med Clin (Barc); 2003 Jun; 121(1):1-5. PubMed ID: 12812701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.
    Kennedy NA; Rhatigan E; Arnott ID; Noble CL; Shand AG; Satsangi J; Lees CW
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1255-66. PubMed ID: 24117596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
    Stocco G; Cuzzoni E; De Iudicibus S; Favretto D; Malusà N; Martelossi S; Pozzi E; Lionetti P; Ventura A; Decorti G
    World J Gastroenterol; 2015 Mar; 21(12):3571-8. PubMed ID: 25834322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Gisbert JP; Gomollón F; Maté J; Pajares JM
    Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
    [No Abstract]   [Full Text] [Related]  

  • 13. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
    Dubinsky MC
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M; Cabello-Tapia MJ; Sánchez-Capilla AD; De Teresa-Galván J; Redondo-Cerezo E
    World J Gastroenterol; 2013 Aug; 19(30):4877-86. PubMed ID: 23946592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.
    Levine JS; Burakoff R
    Inflamm Bowel Dis; 2007 Oct; 13(10):1293-8. PubMed ID: 17567870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
    Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.
    Shah JA; Edwards CM; Probert CS
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):169-73. PubMed ID: 18301295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.
    Carrat F; Seksik P; Colombel JF; Peyrin-Biroulet L; Beaugerie L;
    Aliment Pharmacol Ther; 2017 Feb; 45(4):533-541. PubMed ID: 27995656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
    Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.